Prevalence of disease-modifying drug treatment gaps in patients with multiple sclerosis

被引：0
|
作者：
Joyeux, A.
Kozma, C.
Meletiche, D.
Dickson, M.
Bennett, R.
机构：
[1] Merck Serono, Geneva, Switzerland
[2] Univ S Carolina, Columbia, SC 29208 USA
[3] EMD Serono Inc, Rockland, ME USA
来源：
JOURNAL OF NEUROLOGY | 2009年 / 256卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S163 / S163
页数：1
相关论文
共 50 条
  • [1] PREVALENCE OF TREATMENT GAPS IN MULTIPLE SCLEROSIS PATIENTS RECEIVING DISEASE-MODIFYING DRUGS: FINDINGS FROM A NATIONAL MANAGED CARE DATABASE
    Fincher, C.
    Kozma, C.
    Meletiche, D. M.
    Dickson, M.
    VALUE IN HEALTH, 2009, 12 (03) : A194 - A194
  • [2] Teriflunomide: An orally administered disease-modifying drug for the treatment of multiple sclerosis
    Wojtusik, Amanda
    Feret, Brett
    FORMULARY, 2012, 47 (03) : 97 - 102
  • [3] Disease-Modifying Treatment in Progressive Multiple Sclerosis
    Ciotti, John Robert
    Cross, Anne Haney
    CURRENT TREATMENT OPTIONS IN NEUROLOGY, 2018, 20 (05)
  • [4] Disease-Modifying Treatment in Progressive Multiple Sclerosis
    John Robert Ciotti
    Anne Haney Cross
    Current Treatment Options in Neurology, 2018, 20
  • [5] Current Disease-Modifying Treatment of Multiple Sclerosis
    Derwenskus, Joy
    MOUNT SINAI JOURNAL OF MEDICINE, 2011, 78 (02): : 161 - 175
  • [6] PRIOR DISEASE-MODIFYING DRUG USE AMONG PATIENTS WITH MULTIPLE SCLEROSIS
    Phillips, A. L.
    Kozma, C. M.
    Lorenzo, R.
    Locklear, J.
    VALUE IN HEALTH, 2014, 17 (03) : A67 - A67
  • [7] Audit of patients switching disease-modifying therapies for the treatment of multiple sclerosis
    Embrey, NH
    Woolmore, JA
    Hawkins, CP
    MULTIPLE SCLEROSIS, 2005, 11 : S159 - S159
  • [8] Disease-modifying treatment of secondary progressive multiple sclerosis
    Hoffmann, Olaf
    Gold, Ralf
    NERVENARZT, 2021, 92 (10): : 1052 - 1060
  • [9] Adherence to disease-modifying therapies in patients with multiple sclerosis
    Koltuniuk, Aleksandra
    Rosinczuk, Joanna
    PATIENT PREFERENCE AND ADHERENCE, 2018, 12 : 1557 - 1565
  • [10] Effect of disease-modifying treatment on coronavirus disease 2019 vaccination in patients with multiple sclerosis
    D'haeseleer, M.
    Van Remoortel, A.
    D'hooghe, M.
    Della Faille, L.
    Nagels, G.
    Van Schependom, J.
    EUROPEAN JOURNAL OF NEUROLOGY, 2023, 30 : 429 - 430
12345